BCG vaccine nesting birds and rusted electrical conduits. The resulting closure of the plant for over two years resulting in shortages of bladder cancer and tuberculosis vaccines. On October 29, 2014 Health Canada gave the permission for Sanofi to resume production of BCG. The global supply situation was analyzed in 2017 and concluded that the global supply is sufficient to meet forecasted BCG vaccine demand but risks for shortages remain mainly due to supply concentration. A weakened strain of bovine tuberculosis bacillus, "Mycobacterium bovis" is specially subcultured in a culture medium, usually Middlebrook 7H9. Some BCG vaccines are freeze dried and become
Inoculation needle slant culture to needle, the open end of the culture will be treated with flame and the cap will be replaced. An inoculation needle is used in the transfer of microbial organisms from plate culture to needle by first sterilizing the needle to prevent contaminants. The lid of the agar plate culture is then removed to allow the needle access to the microorganisms cultured on the agar plate. The lid is held hovering above the culture plate to prevent contamination from the surrounding environment. The inoculation needle after incineration is cooled down on an uninoculated region of the agar plate